coronavirus vaccine
Investing in biotech: Where are we now and what is the outlook?
Potential implications of US elections on investors
Investors turn more positive on economy - UBS survey
Return to normality not expected until after July
Taking a shot at recovery: Why 2021 will be the year of the vaccine and not the virus
Block out short-term noise for better rewards
Go big or go home: Will size matter for certain sectors in 2021?
Major changes predicted
Timing is everything during pandemic: How investors can ride the second wave and not drown in it
Deep Dive into global equities
A whole new world: Market recovery on the way but do not expect a return to the old normal
Deep Dive into global equities
A shot of hope: Vaccine and cash injections could spring economy back to life by Q2
Deep Dive into global equities
Calastone: Equity fund inflows surge to £2.4bn in December
Rise driven by vaccine optimism
Vaccine a shot in the arm for cyclical stocks: The global outlook for the next 12 months
Covid jab offers hope of recovery amid lockdowns
Injecting new life: How to fill the gaping hole in support for R&D intensive businesses at late-stage funding
Vaccine breakthrough proves anything is possible
Japan on the rise: New demand source may be needed to sustain equity market's impressive gains
Vaccines and stimulus alone not enough for long term
BNY Mellon Long-Term Global Equity shrugs off vaccine-inspired value rally as 'short-term headwind'
Structural headwinds needed for long-term growth, manager adds
Calastone: Vaccine causes second highest equity flows ever
April remains top month for equity inflows
False dawns or the start of change? The 12 key investment views and trends for 2021
Managers give their sector predictions for next year
IW Long Reads: How much economic damage can a Covid-19 vaccine repair?
Jab news raises hopes - but cannot fix issues alone
IW Long Reads: Is vaccine mania in danger of creating the next bubble that will pop?
Managers fear repeat of dotcom bubble
BofA tells investors to 'sell the vaccine' as fund managers turn bullish
Close to 'full bull'
Shot in the arm or a shot in the dark? Complacency fears over Covid-19 vaccine equity market boost
Market rally too premature, experts warn
Argonaut's Norris: 'Fraud' lockdown was the 'biggest policy error since WWI'
Manager critical of Westminster's response
Investment Week's top ten interviews of 2020
What were the hottest topics to date?
Too early to 'flash the V' for V-shaped recovery sign
Vaccine must arrive before economic scarring
What impact will Covid-19 have on the biotech sector?
After a torrid three weeks, financial markets stabilised in recent days in response to the stimulus packages announced both by central banks and governments.
Most read
